Event Update - ZyCoV-D vaccine approved in increasingly competitive domestic market - BUY
trial of the vaccine on 28,000 volunteers, including 1400 subjects in the age group of 12-17 age group. With favorable and acceptable safety...
162 Views
Event Update - ZyCoV-D vaccine approved in increasingly competitive domestic market - BUY
trial of the vaccine on 28,000 volunteers, including 1400 subjects in the age group of 12-17 age group. With favorable and acceptable safety...
203 Views
Cadila Health Care: Outlook Promising with Strong Pipeline
Cadila Healthcare is India's leading vertically integrated pharmaceutical company. With its presence across the value chain, it manufactures...
270 Views
Cadila Healthcare: Q3FY21 Earnings - Innovation in Focus
Cadila Healthcare reported its Q3FY21 earnings. Most promising aspect for Cadila is its focus on innovation that has been yielding good results...
313 Views
Gland Pharma IPO Trading - Squeezed Through, Now for the Real Test
Gland Pharma raised around US$900m in one of India’s largest IPOs in 2020. The company was established in 1978. KKR invested in 2014 and Fosun...
439 Views